Stock Analyst Rating Reiterations → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsABCBAmeris Bancorp Reiterated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$48.16+1.4% $53.00Equal Weight ➝ Equal WeightAMALAmalgamated Financial Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$24.15+1.1%$28.00 ➝ $29.00Overweight ➝ OverweightAPPFAppFolio Reiterated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$245.29+13.2% $241.00Overweight ➝ OverweightARHSArhaus Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.85+1.8%$17.00 ➝ $17.00Outperform ➝ OutperformASBAssociated Banc Reiterated byStephensSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.85+2.2% $23.00Equal Weight ➝ Equal WeightBPMCBlueprint Medicines Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$92.97+2.5% $125.00Buy ➝ Buy Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BPMCBlueprint Medicines Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$92.97+2.5% $110.00Outperform ➝ OutperformBPMCBlueprint Medicines Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$92.97+2.5% $97.00Buy ➝ BuyBWBBridgewater Bancshares Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$11.71-0.8%$14.50 ➝ $14.00Overweight ➝ OverweightCFRCullen/Frost Bankers Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$108.67-1.9% $115.00Neutral ➝ NeutralCHKPCheck Point Software Technologies Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$151.31-1.1%HoldCHKPCheck Point Software Technologies Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$151.31-1.1% $185.00Outperform ➝ OutperformCLSCelestica Reiterated byCIBCSubscribe to MarketBeat All Access for the recommendation accuracy rating$42.56-1.6%$41.00 ➝ $49.00Sector Outperform ➝ NeutralCMCSAComcast Reiterated byRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$38.41+1.4% $45.00Neutral ➝ NeutralCNOBConnectOne Bancorp Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$18.39-0.4%$27.00 ➝ $24.00Outperform ➝ OutperformCOLBColumbia Banking System Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.55+2.8% $20.00Neutral ➝ NeutralFCNCAFirst Citizens BancShares Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$1,749.75-2.8%$1,900.00 ➝ $2,100.00Outperform ➝ OutperformGILDGilead Sciences Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$65.75+0.7%HoldGOOGLAlphabet Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$172.25+10.4%$160.00 ➝ $200.00Overweight ➝ OverweightHIBBHibbett Reiterated byRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy rating$86.05-0.1%$80.00 ➝ $87.50Outperform ➝ NeutralIMAXIMAX Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.13-1.9% $22.00Outperform ➝ OutperformINBKFirst Internet Bancorp Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.06+1.1%$34.00 ➝ $36.00Market Perform ➝ Market PerformINTCIntel Reiterated byRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.87-9.2%$17.00 ➝ $17.00Sell ➝ SellINTCIntel Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.87-9.2%HoldIPARInter Parfums Reiterated byDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy rating$118.21+0.2%$192.00 ➝ $192.00Buy ➝ BuyJNPRJuniper Networks Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$34.68-0.8%HoldKLACKLA Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$703.32+4.5%HoldLAZLazard Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$38.93+0.1%$51.00 ➝ $49.00Outperform ➝ OutperformLOBLive Oak Bancshares Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.56-2.1%$45.00 ➝ $40.00Market Perform ➝ Market PerformMBLYMobileye Global Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$28.98-6.2% $36.00Buy ➝ BuyMSFTMicrosoft Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$409.66+2.7%$455.00 ➝ $465.00Overweight ➝ OverweightMSFTMicrosoft Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$409.66+2.7% $500.00Outperform ➝ OutperformNBHCNational Bank Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$33.31-1.0%$40.00 ➝ $39.00Market Perform ➝ Market PerformOBKOrigin Bancorp Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$31.44+1.6%$30.00 ➝ $32.00Neutral ➝ NeutralOLPXOlaplex Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.32-0.4%$2.00 ➝ $2.00Market Perform ➝ Market PerformPEGAPegasystems Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$62.65+6.0% $90.00Outperform ➝ OutperformPHATPhathom Pharmaceuticals Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.16+0.7% $26.00Buy ➝ BuyPRAXPraxis Precision Medicines Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$55.04+4.1% $105.00Buy ➝ BuyROKURoku Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$57.58-8.3%$81.00 ➝ $65.00Neutral ➝ NeutralROKURoku Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$57.58-8.3% $100.00Buy ➝ BuyWar Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.Access my report now >>>ROKURoku Reiterated byRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating$57.58-8.3%$89.00 ➝ $89.00Neutral ➝ NeutralRRCRange Resources Reiterated byMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating$37.26-1.0%$39.00 ➝ $41.00Buy ➝ BuyRYTMRhythm Pharmaceuticals Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$37.99-0.4% $50.00Buy ➝ BuySHOOSteven Madden Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$40.91+3.0%$44.00 ➝ $44.00Market Perform ➝ Market PerformSNDXSyndax Pharmaceuticals Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$20.64+0.3% $41.00Buy ➝ BuySPSCSPS Commerce Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$175.54+3.6% $205.00Buy ➝ BuyTDOCTeladoc Health Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$13.27-0.5%HoldTSCOTractor Supply Reiterated byMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy rating$272.85+2.9%$245.00 ➝ $250.00Neutral ➝ NeutralUVSPUnivest Financial Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.22+3.3%$22.00 ➝ $23.00Market Perform ➝ Market PerformWDCWestern Digital Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$69.26-0.3% $85.00Outperform ➝ OutperformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:03 PM ET. Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage. Email Address Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
